I am committed to bringing more oversight and transparency to drug pricing and supporting legislative and administrative solutions so that more families can afford the medicine they need.

As the Chair and Founder of the House Affordable Prescription Drug Task Force, I am committed to bringing more oversight and transparency to drug pricing and supporting legislative and administrative solutions so that more families can afford the medicine they need.

Doggett commits to increased oversight and transparency on drug pricing and to supporting solutions that lower medication costs.

Issues | Congressman Lloyd Doggett
primary · campaign_site · model gpt-5.4-mini

House Roll Call 420 on H.R. 5376 passed, 220-207. The vote list records Doggett, Democratic, Texas: Yea.

Doggett voted for the Inflation Reduction Act legislative vehicle that became the basis for Medicare drug-price negotiation and other drug-affordability provisions.

partial unknown A for effort

Office of the Clerk, U.S. House of Representatives: Roll Call 420, H.R. 5376
secondary · model gpt-5.5 · confidence 90%

CMS says the first 10 negotiated Medicare Part D prices go into effect January 1, 2026, with projected enrollee savings of $1.5 billion.

The enacted drug-pricing program Doggett supported has reached administrative implementation, delivering a concrete affordability measure for Medicare beneficiaries, though the broader promise remains only partially fulfilled.

partial same_term

CMS: Medicare Drug Price Negotiation Program, Negotiated Prices for Initial Price Applicability Year 2026
secondary · model gpt-5.5 · confidence 88%

CMS announced 15 additional Medicare Part D drugs for direct price negotiation, said negotiations would occur in 2025, and said any negotiated prices would take effect in 2027. The same release said the first-cycle negotiated prices would take effect on January 1, 2026 and were expected to produce additional beneficiary savings.

Concrete administrative follow-through on drug-pricing reform, with new negotiations and scheduled price reductions that advance the promise of more affordability and transparency, though the broader pledge is not fully exhausted.

partial same_term

CMS: HHS Announces 15 Additional Drugs Selected for Medicare Drug Price Negotiations in Continued Effort to Lower Prescription Drug Costs for Seniors
secondary · model gpt-5.4-mini · confidence 95%

Doggett voted Yea on H.R. 5376, the reconciliation vehicle that became the Inflation Reduction Act and created Medicare drug-price negotiation authority.

Clear legislative support for drug-pricing reform and the later administrative program that followed from it.

partial same_term A for effort

Office of the Clerk, U.S. House of Representatives: Roll Call 420, H.R. 5376
secondary · model gpt-5.4-mini · confidence 98%